_:n593b09c66c9247c2980583ef13f97ba9xb5
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://oncxerna.com/oncxerna-therapeutics-announces-journal-of-clinical-oncology-publication-featuring-phase-1b-data-of-navicixizumab-plus-paclitaxel-in-ovarian-cancer/>